Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | NSD2 | O96028 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.42 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.41 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.40 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11561649 | 0.92 | AKR1C2 (0.47) | GABRA1GABRB2MEN1KMT2AALDH1A1 | |
| SCHEMBL10469464 | 0.90 | GABRA1 (0.41) | GABRA1GABRB2MEN1KMT2AALDH1A1 | |
| SCHEMBL4075760 | 0.88 | NR5A2 (0.55) | GABRA1GABRB2MEN1KMT2AALDH1A1 | |
| SCHEMBL11289049 | 0.86 | MEN1 (0.44) | GABRA1GABRB2MEN1KMT2AALDH1A1 | |
| SCHEMBL10395320 | 0.86 | HIF1A (0.48) | GABRA1GABRB2MEN1KMT2AALDH1A1 | |
| SCHEMBL10712901 | 0.83 | ALDH1A1 (0.36) | GABRA1GABRB2MEN1KMT2AALDH1A1 | |
| SCHEMBL6971420 | 0.83 | GAA (0.47) | MEN1KMT2AALDH1A1KDM4ELMNA | |
| SCHEMBL28717119 | 0.82 | AKR1C2 (0.53) | GABRA1GABRB2MEN1KMT2AALDH1A1 | |
| SCHEMBL11349479 | 0.82 | CYP2C19 (0.42) | GABRA1GABRB2MEN1KMT2AALDH1A1 | |
| Hydrochloric Acid SCHEMBL11340256 | 0.80 | PLG (0.43) | GABRA1GABRB2MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3312214-B1 | METHOD OF SYNTHESISING POLYCARBONATES IN THE PRESENCE OF A BIMETALLIC CATALYST AND A CHAIN TRANSFER AGENT | IMPERIAL INNOVATIONS LTD (GB) | 2023-08-16 | — | — | EP | disclosed |
| CN-108707225-B | Method for synthesizing polycarbonate in presence of bimetallic catalyst and chain transfer agent | IP2IPO创新有限公司 | 2021-07-02 | — | — | CN | disclosed |
| EP-3312214-A1 | METHOD OF SYNTHESISING POLYCARBONATES IN THE PRESENCE OF A BIMETALLIC CATALYST AND A CHAIN TRANSFER AGENT | Imperial Innovations Limited (GB) | 2018-04-25 | — | — | EP | disclosed |
| EP-2753651-B1 | METHOD OF SYNTHESISING POLYCARBONATES IN THE PRESENCE OF A BIMETALLIC CATALYST AND A CHAIN TRANSFER AGENT | IMP INNOVATIONS LTD (GB) | 2017-07-12 | — | — | EP | disclosed |
| US-9006347-B2 | Method of synthesising polycarbonates in the presence of a bimetallic catalyst and a chain transfer agent | IMPERIAL INNOVATIONS LIMITED (GB) | 2015-04-14 | — | — | US | disclosed |
| US-20140249279-A1 | METHOD OF SYNTHESISING POLYCARBONATES IN THE PRESENCE OF A BIMETALLIC CATALYST AND A CHAIN TRANSFER AGENT | IMPERIAL INNOVATIONS LIMITED (GB) | 2014-09-04 | — | — | US | disclosed |
| WO-2013034750-A9 | METHOD OF SYNTHESISING POLYCARBONATES IN THE PRESENCE OF A BIMETALLIC CATALYST AND A CHAIN TRANSFER AGENT | IMPERIAL INNOVATIONS LIMITED (GB) | 2013-09-06 | — | — | WO | disclosed |
| WO-2013034750-A2 | METHOD OF SYNTHESISING POLYCARBONATES IN THE PRESENCE OF A BIMETALLIC CATALYST AND A CHAIN TRANSFER AGENT | IMPERIAL INNOVATIONS LIMITED (GB) | 2013-03-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140249279-A1 | METHOD OF SYNTHESISING POLYCARBONATES IN THE PRESENCE OF A BIMETALLIC CATALYST AND A CHAIN TRANSFER AGENT | TECR, MCM4, PCCA | GABRA1 2959/4885GABRB2 3419/4885MEN1 1217/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.